FMR LLC

Insider Reports History

Location
Boston, MA
Signature
/s/ Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by FMR LLC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Flywire Corp Other* Common Stock 7,268,490 $135,059,447 $18.58 28 May 2021 F-Prime Capital Partners Tech Fund LP
Toast, Inc. Other* Class B Common Stock 6,703,780 $113,421,254 $16.92 09 Nov 2021 F-Prime Capital Partners Tech Fund LP
Neumora Therapeutics, Inc. Other* Common Stock 5,472,340 $65,558,633 $11.98 19 Sep 2023 F-Prime Capital Partners Life Sciences Fund VII LP
Prime Medicine, Inc. Other* Common Stock 4,228,589 $63,306,629 $14.97 24 Oct 2022 Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned
Prime Medicine, Inc. Other* Common Stock 4,124,375 $61,746,431 $14.97 24 Oct 2022 F-Prime Capital Partners Life Sciences Fund VI LP
Beam Therapeutics Inc. Other*, 10%+ Owner Common Stock 1,139,443 $27,654,281 $24.27 27 Oct 2025 F-Prime Capital Partners Healthcare Fund V LP
Structure Therapeutics Inc. Other*, 10%+ Owner American Depositary Shares 1,515,558 $27,083,021 $17.87 15 Jan 2026 Shares held by persons and entities whose shares are subject to reporting by the undersigned
Beam Therapeutics Inc. Other*, 10%+ Owner Common Stock 841,231 $20,416,676 $24.27 27 Oct 2025 Shares held by persons and entities whose shares are subject to reporting by the undersigned.
Structure Therapeutics Inc. Other*, 10%+ Owner Ordinary Shares 241,275 $16,780,676 $69.55 15 Jan 2026 F-Prime Capital Partners Life Sciences Fund VI LP
Bicara Therapeutics Inc. Other* Common Stock 1,115,333 $14,770,801 $13.24 16 Sep 2024 F-Prime Capital Partners Life Sciences Fund VII LP
Rallybio Corp Other* Common Stock 1,694,388 $8,827,761 $5.21 02 Aug 2021 F-Prime Capital Partners Life Sciences Fund VI LP
Sana Biotechnology, Inc. Other*, 10%+ Owner Common Stock 4,541,511 $7,493,493 $1.65 08 Jan 2025 F-Prime Capital Partners Life Sciences Fund VI LP
Verve Therapeutics, Inc. Other* Common Stock 570,729 $5,707,290 $10.00 26 Jul 2022 F-Prime Capital Partners Healthcare Fund V LP
Caribou Biosciences, Inc. Other* Common Stock 1,840,937 $5,449,174 $2.96 27 Jul 2021 F-Prime Capital Partners Healthcare Fund IV LP
Structure Therapeutics Inc. Other*, 10%+ Owner American Depositary Shares 58,864 $4,832,734 $82.10 15 Jan 2026 F-Prime Capital Partners Life Sciences Fund VI LP LP
Caribou Biosciences, Inc. Other* Common Stock 1,464,775 $4,335,734 $2.96 27 Jul 2021 Impresa Fund III Limited Partnership
Structure Therapeutics Inc. Other*, 10%+ Owner American Depositary Shares 48,256 $4,103,690 $85.04 15 Jan 2026 F-Prime Capital Partners Life Sciences Fund VI LP
Prime Medicine, Inc. Other* Common Stock 109,982 $1,646,552 $14.97 24 Oct 2022 F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Structure Therapeutics Inc. Other*, 10%+ Owner Ordinary Shares 20,502 $1,425,914 $69.55 15 Jan 2026 F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Xilio Therapeutics, Inc. Other* Common Stock 1,530,990 $1,270,722 $0.8300 26 Oct 2021 F-Prime Capital Partners Healthcare Fund IV LP
Neumora Therapeutics, Inc. Other* Common Stock 88,289 $1,057,702 $11.98 19 Sep 2023 FBRI LLC
Neumora Therapeutics, Inc. Other* Common Stock 63,724 $763,414 $11.98 19 Sep 2023 F-Prime Inc.
Structure Therapeutics Inc. Other*, 10%+ Owner American Depositary Shares 4,103 $348,919 $85.04 15 Jan 2026 F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Xilio Therapeutics, Inc. Other* Common Stock 372,215 $308,938 $0.8300 26 Oct 2021 Impresa Fund III Limited Partnership
Caribou Biosciences, Inc. Other* Common Stock 17,572 $52,013 $2.96 27 Jul 2021 F-Prime Capital Partners Healthcare Advisors Fund IV LP
Fidelity Private Credit Fund Other* Class D Common Shares of Beneficial Interest 398 $10,163 $25.54 29 Jan 2024 FMR Capital Inc.
Fidelity Private Credit Fund Other* Class S Common Shares of Beneficial Interest 398 $10,153 $25.54 29 Jan 2024 FMR Capital Inc.
Xilio Therapeutics, Inc. Other* Common Stock 4,465 $3,706 $0.8300 26 Oct 2021 F-Prime Capital Partners Healthcare Advisors Fund IV LP
Beam Therapeutics Inc. Other*, 10%+ Owner Common Stock 14 $373 $26.68 27 Oct 2025 FMR Capital, Inc.
Sana Biotechnology, Inc. Other*, 10%+ Owner Common Stock 61 $101 $1.65 08 Jan 2025 FMR Capital, Inc.
Metsera, Inc. Other*, 10%+ Owner Common Stock 0 $0 $52.51 13 Nov 2025 F-Prime Inc.
Metsera, Inc. Other*, 10%+ Owner Common Stock 0 $0 $52.51 13 Nov 2025 Shares held by persons and entities whose shares are subject to reporting by the undersigned.
Structure Therapeutics Inc. Other*, 10%+ Owner American Depositary Shares 0 $0 $30.54 06 Feb 2025 FIMM, LLC
Fidelity Multi-Strategy Credit Fund Other*, 10%+ Owner Common Shares of Beneficial Ownership 2,500,000 19 May 2023 Direct
Fidelity Private Credit Fund Other* Class I Common Shares of Beneficial Interest 1,280,002 29 Jan 2024 Direct
Turnstone Biologics Corp. Other* Common Stock 832,652 09 Jan 2024 F-Prime Capital Partners Healthcare Fund V LP
Fidelity Private Credit Fund Other* Class I Common Shares of Beneficial Interest 352,360 29 Jan 2024 Fidelity Multi-Strategy Credit Fund
Turnstone Biologics Corp. Other* Common Stock 296,396 09 Jan 2024 Impresa Fund III Limited Partnership
Turnstone Biologics Corp. Other* Common Stock 4,939 09 Jan 2024 F-Prime Capital Partners Healthcare Advisors Fund V LP
Fidelity Private Credit Fund Other* Class I Common Shares of Beneficial Interest 86 29 Jan 2024 FMR Capital Inc.
Bicara Therapeutics Inc. Other* Series B Preferred Stock 0 16 Sep 2024 F-Prime Capital Partners Life Sciences Fund VII LP
Bicara Therapeutics Inc. Other* Series C Preferred Stock 0 16 Sep 2024 F-Prime Capital Partners Life Sciences Fund VII LP
Bicara Therapeutics Inc. Other* Series Seed Preferred Stock 0 16 Sep 2024 F-Prime Capital Partners Life Sciences Fund VII LP
Caribou Biosciences, Inc. Other* Series A-1 Preferred Stock 0 27 Jul 2021 F-Prime Capital Partners Healthcare Advisors Fund IV LP
Caribou Biosciences, Inc. Other* Series A-1 Preferred Stock 0 27 Jul 2021 F-Prime Capital Partners Healthcare Fund IV LP
Caribou Biosciences, Inc. Other* Series A-1 Preferred Stock 0 27 Jul 2021 Impresa Fund III Limited Partnership
Caribou Biosciences, Inc. Other* Series B Preferred Stock 0 27 Jul 2021 F-Prime Capital Partners Healthcare Fund IV LP
Flywire Corp Other* Series A Preferred Stock 0 28 May 2021 F-Prime Capital Partners Tech Fund LP
Flywire Corp Other* Series B-1 NV Preferred Stock 0 28 May 2021 F-Prime Capital Partners Tech Fund LP
Flywire Corp Other* Series B-1 Preferred Stock 0 28 May 2021 F-Prime Capital Partners Tech Fund LP
Flywire Corp Other* Series B Preferred Stock 0 28 May 2021 F-Prime Capital Partners Tech Fund LP
Flywire Corp Other* Series C Preferred Stock 0 28 May 2021 F-Prime Capital Partners Tech Fund LP
Metsera, Inc. Other*, 10%+ Owner Series A Preferred Stock 0 03 Feb 2025 F-Prime Capital Partners Life Sciences Fund VIII LP
Metsera, Inc. Other*, 10%+ Owner Series Seed Preferred Stock 0 03 Feb 2025 F-Prime Capital Partners Life Sciences Fund VIII LP
Neumora Therapeutics, Inc. Other* Series A-2 Preferred Stock 0 19 Sep 2023 FBRI LLC
Neumora Therapeutics, Inc. Other* Series A-2 Preferred Stock 0 19 Sep 2023 F-Prime Capital Partners Life Sciences Fund VII LP
Neumora Therapeutics, Inc. Other* Series A-2 Preferred Stock 0 19 Sep 2023 F-Prime Inc.
Neumora Therapeutics, Inc. Other* Series B Preferred Stock 0 19 Sep 2023 F-Prime Capital Partners Life Sciences Fund VII LP
Prime Medicine, Inc. Other* Series A Convertible Preferred Stock 0 24 Oct 2022 Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned
Prime Medicine, Inc. Other* Series A Convertible Preferred Stock 0 24 Oct 2022 F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Prime Medicine, Inc. Other* Series A Convertible Preferred Stock 0 24 Oct 2022 F-Prime Capital Partners Life Sciences Fund VI LP
Prime Medicine, Inc. Other* Series B Convertible Preferred Stock 0 24 Oct 2022 Entity managed by Impresa Management LLC whose shares are subject to reporting by the Undersigned
Prime Medicine, Inc. Other* Series B Convertible Preferred Stock 0 24 Oct 2022 F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Rallybio Corp Other* Series B Preferred Units 0 02 Aug 2021 F-Prime Capital Partners Life Sciences Fund VI LP
Turnstone Biologics Corp. Other* Series B-1 Preferred Stock 0 25 Jul 2023 F-Prime Capital Partners Healthcare Fund V LP
Turnstone Biologics Corp. Other* Series B-2 Preferred Stock 0 25 Jul 2023 F-Prime Capital Partners Healthcare Advisors Fund V LP
Turnstone Biologics Corp. Other* Series B-2 Preferred Stock 0 25 Jul 2023 F-Prime Capital Partners Healthcare Fund V LP
Turnstone Biologics Corp. Other* Series B-2 Preferred Stock 0 25 Jul 2023 Impresa Fund III Limited Partnership
Turnstone Biologics Corp. Other* Series C Preferred Stock 0 25 Jul 2023 F-Prime Capital Partners Healthcare Fund V LP
Turnstone Biologics Corp. Other* Series D Preferred Stock 0 25 Jul 2023 F-Prime Capital Partners Healthcare Fund V LP
Xilio Therapeutics, Inc. Other* Series A-1 Preferred Stock 0 26 Oct 2021 F-Prime Capital Partners Healthcare Fund IV LP
Xilio Therapeutics, Inc. Other* Series A Preferred Stock 0 26 Oct 2021 F-Prime Capital Partners Healthcare Fund IV LP
Xilio Therapeutics, Inc. Other* Series B Preferred Stock 0 26 Oct 2021 F-Prime Capital Partners Healthcare Advisors Fund IV LP
Xilio Therapeutics, Inc. Other* Series B Preferred Stock 0 26 Oct 2021 F-Prime Capital Partners Healthcare Fund IV LP
Xilio Therapeutics, Inc. Other* Series B Preferred Stock 0 26 Oct 2021 Impresa Fund III Limited Partnership

Insider Reports Filed by FMR LLC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GPCR Structure Therapeutics Inc. 15 Jan 2026 8 -$1,453,753 4 Other*, 10%+ Owner 20 Jan 2026, 09:22
GPCR Structure Therapeutics Inc. 08 Dec 2025 10 -$3,768,430 4 Other*, 10%+ Owner 10 Dec 2025, 14:07
MTSR Metsera, Inc. 13 Nov 2025 2 $0 4 Other*, 10%+ Owner 17 Nov 2025, 13:51
MTSR Metsera, Inc. 10 Nov 2025 1 $0 4 Other*, 10%+ Owner 12 Nov 2025, 10:48
MTSR Metsera, Inc. 03 Nov 2025 8 -$11,817 4 Other*, 10%+ Owner 05 Nov 2025, 09:57
BEAM Beam Therapeutics Inc. 27 Oct 2025 1 -$12,246 4 Other*, 10%+ Owner 29 Oct 2025, 13:13
BEAM Beam Therapeutics Inc. 06 Oct 2025 1 $0 4 Other*, 10%+ Owner 08 Oct 2025, 15:37
MTSR Metsera, Inc. 06 Oct 2025 1 $0 4 Other*, 10%+ Owner 08 Oct 2025, 15:35
MTSR Metsera, Inc. 02 Sep 2025 1 $0 4/A Other*, 10%+ Owner 12 Sep 2025, 16:09
BEAM Beam Therapeutics Inc. 30 Jul 2025 1 -$991,667 4 Other*, 10%+ Owner 01 Aug 2025, 09:36
GPCR Structure Therapeutics Inc. 30 Jul 2025 1 -$470,160 4 Other*, 10%+ Owner 01 Aug 2025, 09:34
BEAM Beam Therapeutics Inc. 31 Mar 2025 0 $0 3 Other*, 10%+ Owner 10 Apr 2025, 09:36
GPCR Structure Therapeutics Inc. 06 Feb 2025 1 -$1,252 4 Other*, 10%+ Owner 10 Feb 2025, 08:36
MTSR Metsera, Inc. 03 Feb 2025 4 $0 4 Other*, 10%+ Owner 05 Feb 2025, 11:39
MTSR Metsera, Inc. 30 Jan 2025 0 $0 3 Other*, 10%+ Owner 30 Jan 2025, 18:28
SANA Sana Biotechnology, Inc. 08 Jan 2025 4 -$1,887,320 4 Other*, 10%+ Owner 10 Jan 2025, 13:32
BCAX Bicara Therapeutics Inc. 16 Sep 2024 6 $0 4 Other* 18 Sep 2024, 11:54
BCAX Bicara Therapeutics Inc. 12 Sep 2024 0 $0 3 Other*, 10%+ Owner 12 Sep 2024, 21:00
GPCR Structure Therapeutics Inc. 06 Jun 2024 0 $0 3 Other*, 10%+ Owner 13 Jun 2024, 09:07
GPCR Structure Therapeutics Inc. 17 Apr 2024 0 $0 4 Other* 19 Apr 2024, 14:13
SANA Sana Biotechnology, Inc. 01 Apr 2024 0 $0 3/A Other*, 10%+ Owner 21 Nov 2024, 13:19
GPCR Structure Therapeutics Inc. 14 Mar 2024 1 -$769,895 4 Other*, 10%+ Owner 18 Mar 2024, 08:52
BEAM Beam Therapeutics Inc. 13 Feb 2024 4 -$27,545,051 4 Other* 15 Feb 2024, 14:34
GPCR Structure Therapeutics Inc. 13 Feb 2024 1 -$24,801 4 Other*, 10%+ Owner 15 Feb 2024, 11:11
/report/000120919124002460-fmr-llc-2024-01-29 Fidelity Private Credit Fund 29 Jan 2024 0 $0 4 Other* 31 Jan 2024, 08:54
TSBX Turnstone Biologics Corp. 09 Jan 2024 0 $0 4 Other* 11 Jan 2024, 15:43
BEAM Beam Therapeutics Inc. 22 Dec 2023 1 $0 4 Other*, 10%+ Owner 27 Dec 2023, 10:56
GPCR Structure Therapeutics Inc. 22 Dec 2023 1 $0 4 Other*, 10%+ Owner 27 Dec 2023, 10:49
GPCR Structure Therapeutics Inc. 05 Dec 2023 2 -$1,090,177 4 Other*, 10%+ Owner 07 Dec 2023, 11:04
/report/000120919123056886-fmr-llc-2023-11-29 Fidelity Private Credit Fund 29 Nov 2023 2 +$19,998 4 Other*, 10%+ Owner 29 Nov 2023, 14:57
GPCR Structure Therapeutics Inc. 18 Oct 2023 2 -$1,145,681 4 Other*, 10%+ Owner 23 Oct 2023, 15:55
GPCR Structure Therapeutics Inc. 02 Oct 2023 0 $0 3 Other*, 10%+ Owner 12 Oct 2023, 08:55
NMRA Neumora Therapeutics, Inc. 19 Sep 2023 8 $0 4 Other* 21 Sep 2023, 09:30
NMRA Neumora Therapeutics, Inc. 14 Sep 2023 0 $0 3 Other*, 10%+ Owner 14 Sep 2023, 20:01
TSBX Turnstone Biologics Corp. 25 Jul 2023 12 $0 4 Other*, 10%+ Owner 27 Jul 2023, 08:42
TSBX Turnstone Biologics Corp. 20 Jul 2023 0 $0 3 Other*, 10%+ Owner 20 Jul 2023, 21:03
/report/000120919123040138-fmr-llc-2023-06-27 Fidelity Private Credit Fund 27 Jun 2023 1 +$8,747,816 4 Other*, 10%+ Owner 29 Jun 2023, 09:48
/report/000120919123032369-fmr-llc-2023-05-19 Fidelity Multi-Strategy Credit Fund 19 May 2023 0 $0 3 Other*, 10%+ Owner 26 May 2023, 07:45
/report/000120919123020702-fmr-llc-2023-03-13 Fidelity Private Credit Fund 13 Mar 2023 0 $0 3 Other*, 10%+ Owner 23 Mar 2023, 11:49
GPCR Structure Therapeutics Inc. 07 Feb 2023 18 $0 4 Other* 09 Feb 2023, 13:42
GPCR Structure Therapeutics Inc. 02 Feb 2023 0 $0 3 Other*, 10%+ Owner 02 Feb 2023, 17:11
PRME Prime Medicine, Inc. 24 Oct 2022 10 $0 4 Other* 26 Oct 2022, 12:23
PRME Prime Medicine, Inc. 19 Oct 2022 0 $0 3 Other*, 10%+ Owner 19 Oct 2022, 20:24
BEAM Beam Therapeutics Inc. 06 Sep 2022 3 -$29,892 4 Other*, 10%+ Owner 08 Sep 2022, 11:04
BEAM Beam Therapeutics Inc. 04 Aug 2022 9 -$1,229,806 4 Other*, 10%+ Owner 08 Aug 2022, 16:49
VERV Verve Therapeutics, Inc. 26 Jul 2022 0 $0 4 Other* 28 Jul 2022, 08:31
VERV Verve Therapeutics, Inc. 12 Jul 2022 2 -$3,386,520 4 Other*, 10%+ Owner 14 Jul 2022, 17:24
VERV Verve Therapeutics, Inc. 01 Jul 2022 1 -$607,216 4 Other*, 10%+ Owner 06 Jul 2022, 12:56
VERV Verve Therapeutics, Inc. 29 Jun 2022 3 -$822,476 4 Other*, 10%+ Owner 01 Jul 2022, 14:54
BEAM Beam Therapeutics Inc. 12 Apr 2022 11 -$981,205 4 Other*, 10%+ Owner 14 Apr 2022, 17:13
VERV Verve Therapeutics, Inc. 09 Mar 2022 1 -$115,199 4 Other*, 10%+ Owner 11 Mar 2022, 16:59
VERV Verve Therapeutics, Inc. 09 Feb 2022 1 -$388,577 4 Other*, 10%+ Owner 11 Feb 2022, 09:40
VERV Verve Therapeutics, Inc. 01 Feb 2022 1 -$1,033,069 4 Other*, 10%+ Owner 03 Feb 2022, 10:43
VERV Verve Therapeutics, Inc. 26 Jan 2022 5 -$4,943,419 4 Other*, 10%+ Owner 28 Jan 2022, 16:04
BEAM Beam Therapeutics Inc. 20 Jan 2022 0 $0 3 Other*, 10%+ Owner 24 Jan 2022, 07:53
VERV Verve Therapeutics, Inc. 23 Dec 2021 0 $0 3 Other*, 10%+ Owner 28 Dec 2021, 11:16
TOST Toast, Inc. 09 Nov 2021 0 $0 4 Other* 12 Nov 2021, 07:41
XLO Xilio Therapeutics, Inc. 26 Oct 2021 10 $0 4 Other* 28 Oct 2021, 15:45
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 Other*, 10%+ Owner 21 Oct 2021, 20:49
TOST Toast, Inc. 24 Sep 2021 0 $0 3 Other*, 10%+ Owner 04 Oct 2021, 19:16
BEAM Beam Therapeutics Inc. 24 Aug 2021 7 $0 4 Other* 26 Aug 2021, 15:48
BEAM Beam Therapeutics Inc. 06 Aug 2021 7 $0 4/A Other*, 10%+ Owner 16 Aug 2021, 17:14
RLYB Rallybio Corp 02 Aug 2021 2 $0 4 Other* 04 Aug 2021, 15:23
RLYB Rallybio Corp 29 Jul 2021 0 $0 3 Other*, 10%+ Owner 29 Jul 2021, 10:00
CRBU Caribou Biosciences, Inc. 27 Jul 2021 8 $0 4 Other* 29 Jul 2021, 14:52
CRBU Caribou Biosciences, Inc. 22 Jul 2021 0 $0 3 Other*, 10%+ Owner 22 Jul 2021, 17:04
VERV Verve Therapeutics, Inc. 21 Jun 2021 4 $0 4 Other* 23 Jun 2021, 11:36
VERV Verve Therapeutics, Inc. 16 Jun 2021 0 $0 3 Other*, 10%+ Owner 16 Jun 2021, 17:33
FLYW Flywire Corp 28 May 2021 10 $0 4 Other* 02 Jun 2021, 16:58
FLYW Flywire Corp 25 May 2021 0 $0 3 Other*, 10%+ Owner 26 May 2021, 15:50